glp 1 agonisté glp-1_analogs [TUSOM Analogues du GLP-1 et agonistes
Description
[DOI] [PubMed] [Google Scholar] 42.Ridker P.M
Burke OM, Sa B, Cespedes DA, Tosti A
Cherney DZI, Bjornstad P, Perkins BA et al (2021) Kidney effects of empagliflozin in people with type 1 diabetes
They're stigmatized for losing weight
Recent data from Eli Lilly's tirzepatide, may present a serious challenge to Novo Nordisks dominant position in the anti-obesity space
